Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1975
Drug-induced phospholipidosis. II. Alterations in the phospholipid pattern of organs from mice, rats and guinea-pigs after chronic treatment with chlorphentermineK U Seiler, O WassermannDeutsche Medizinische Wochenschrift (1946)|January 4, 1980
[Pharmacokinetics of gold after administration of aurokeratinate (author's transl)]J D Herrlinger, K U SeilerArzneimittel-Forschung|January 10, 2001
Pharmacokinetics of nortilidine and naloxone after administration of tilidine/naloxone solution or tilidine/naloxone sustained release tabletsU Brennscheidt, K U Seiler, P ThomannClinical and Experimental Pharmacology & Physiology|July 1, 1976
On the role of serotonin in the pathogenesis of pulmonary hypertension induced by anorectic drugs; an experimental study in the isolated perfused rat lung, II. Fenfluramine, mazindol, mefenorex, phentermine and R 800K U Seiler, O Wassermann, H WenskyArzneimittel-Forschung|January 1, 1977
[Modification-possibility of the enterohepatic circulation of digitoxin in man]R W Sattler, W Schmiedeberg, K U SeilerKlinische Monatsblatter Fur Augenheilkunde|January 1, 1977
[Chloroquine keratopathy as an example of drug-induced phospholipidosis (contribution to the pathogenesis of cornea verticillata) (author's transl)]K U Seiler, H J Thiel, O WassermannArzneimittel-Forschung|January 1, 1979
[Studies on the competition of several antibiotics for binding sites to serum protein (author's transl)]V Malerczyk, W Ruegenberg, K U Seiler, et al.British Journal of Pharmacology|April 1, 1971
Plasma concentration, uptake by liver, and biliary excretion of tritiated cardiac glycosides in the isolated perfused guinea-pig liverK D Kolenda, H Lüllmann, T Peters, et al.Journal of Clinical Pharmacology|January 6, 2001
Pharmacokinetics of tilidine in terminal renal failureK U Seiler, E Jähnchen, D Trenk, et al.European Journal of Clinical Pharmacology|August 22, 2000
Intravesical administration of 5-aminolevulinic acid (5-ALA). Safety and pharmacokinetics of 5-ALA and its metabolite protoporphyrin IXG Popken, W Schultze-Seemann, K U Seiler, et al.Pageof 2